Actively Recruiting
Lateral Plantar Artery Embolization For Plantar Fasciitis
Led by Joint & Vascular Institute · Updated on 2026-02-09
10
Participants Needed
1
Research Sites
62 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are: Does this procedure successfully reduce chronic heel pain as measured by the Visual Analog Scale (VAS) over 12 months? How safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device? Participants will: Undergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels in the foot. Receive a phone call one day after the procedure to check for early side effects. Participate in four follow-up telehealth visits over the course of one year (at 1, 3, 6, and 12 months). Complete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.
CONDITIONS
Official Title
Lateral Plantar Artery Embolization For Plantar Fasciitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 25 years or older
- Provides written informed consent
- Diagnosed with plantar fasciitis not improved after 3 months of conservative treatment
- Reports heel pain of at least 4 out of 10 on a visual analog scale
- Not a candidate for surgery or wishes to avoid surgery
You will not qualify if you...
- Heel pain caused by acute fracture, recent trauma, inflammatory conditions, muscle or ligament injury, or bone mineral density issues
- Received steroid injection in the heel within 90 days before the procedure
- Known severe allergy to Lipiodol or iodinated contrast media
- Diagnosed with peripheral arterial disease affecting the lower limbs
- Currently pregnant or breastfeeding
- Taking anticoagulants or has irreversible blood clotting disorders
- Kidney function with GFR less than 45 or serum creatinine over 2.0 mg/dl
- Has type 1 diabetes mellitus
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Joint and Vascular Institute
Libertyville, Illinois, United States, 60048
Actively Recruiting
Research Team
L
Layth Alkhani
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here